PAX5 and hepatocellular carcinoma: It is noteworthy that the expression levels for YMO1 positively correlated with PAX5 expressions in all HCC samples analyzed (P = 0.004, Supplementary Table S7), in which the absence of recurrence was associated with the high levels of YMO1 and PAX5 expressions in HCC samples.